| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8466588 | Cytotherapy | 2018 | 9 Pages |
Abstract
In conclusion, for pre-emptive therapy of PTLD, we suggest threshold DNAemia of 100,000-500,000âIU/mL. Persistently detectable DNAemia after PTLD treatment with rituximab appears to have 71% positive predictive value and 100% negative predictive value for PTLD progression/relapse.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Amit Kalra, Cameron Roessner, Jennifer Jupp, Tyler Williamson, Raymond Tellier, Ahsan Chaudhry, Faisal Khan, Minakshi Taparia, Victor H. Jimenez-Zepeda, Douglas A. Stewart, Andrew Daly, Jan Storek,